NCT01787331View on ClinicalTrials.gov

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 29, 2013

Primary Completion Date

May 30, 2017

Study Completion Date

September 30, 2018

Conditions
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7
Interventions
DRUG

Itraconazole

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Correlative studies

Trial Locations (1)

94115

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT01787331 - Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer | Biotech Hunter | Biotech Hunter